What does the evidence say about Selenium Thyroid Hormone Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Selenium Thyroid Hormone Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Subclinical hypothyroidism has been associated with metabolic disturbances, increased cardiovascular risk, and reduced quality of life, highlighting the need for effective management strategies [,]. [Stanchev Pavel (2026); evidence level 1] - It is thought to enhance TSH signaling and support thyroid hormone synthesis, with emerging clinical evidence suggesting a beneficial effect on thyroid function parameters []. [Stanchev Pavel (2026); evidence level 1] - Despite these promising findings, the available evidence remains limited, and there is currently no consensus regarding the clinical benefit of combination therapy over selenium alone. [Stanchev Pavel (2026); evidence level 1] - 1 2 3 2 3 Hashimoto’s thyroiditis (HT) is the most common autoimmune thyroid disorder and the leading cause of hypothyroidism in iodine-sufficient regions worldwide []. [Stanchev Pavel (2026); evidence level 1] - It is associated with elevated anti-thyroid peroxidase antibodies (TPOAb) and often anti-thyroglobulin antibodies (TgAb) (). [Personius Lydia (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.